We serve Chemical Name:(1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine CAS:34887-52-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine
CAS.NO:34887-52-0
Synonyms:(1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine
Molecular Formula:C16H16FNO
Molecular Weight:257.30300
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:365.2ºC at 760mmHg
Density:1.18g/cm3
Index of Refraction:1.593
PSA:21.26000
Exact Mass:257.12200
LogP:3.42420
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine Use and application,(1R,3R)-7-Fluoro-N-methyl-1-phenyl-3,4-dihydro-1H-isochromen-3-am ine technical grade,usp/ep/jp grade.
Related News: The results provided a formulation amenable to two dosage strengths by applying a proportional dosing weight method.” The product is currently in late-stage development with the New Drug Application filing expected in late 2021. 1,5-bis-(6-nitro-benzothiazol-2-yl)-formazan manufacturers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. N-Benzoyl-glycin-tritylester suppliers As further tools are created to improve biocatalyst development, these can likewise be assessed for their capacity to add value to a project. 3-(N-(2-benzyl-6-fluoro-4-oxoquinazolin-3(4H)-yl)sulfamoyl)benzoic acid vendor & factory The company’s contract arm churns out more than 250 metric tons of commercial APIs every year for injectables, inhalables, highly potent, cytotoxic and controlled substances, according to a release.,ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged.
